Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma
Rate of disease-free survival at 24 months higher with pembrolizumab versus placebo following nephrectomy
Previous Tx in Metastatic Melanoma May Cut Response to ACT TIL
Prior therapy linked to lower objective response rate to adoptive cell transfer with tumor-infiltrating lymphocytes compared with no prior therapy
High-Intensity Interval Training Beneficial in Prostate Cancer
PSA level, velocity, and prostate cancer cell growth reduced with HIIT in men with localized prostate cancer under active surveillance
FDA: Stop Using Eco-Med Ultrasound Gels, Lotions
Health care providers, facilities should stop using and discard all ultrasound gels and lotions due to risk for bacterial contamination
Early-Onset CRC Biologically Similar to Average-Onset CRC
No significant differences seen at gene or pathway level according to age; chemotherapy response, survival equivalent by age groups
Blacks Remain Underrepresented in U.S. Medical School Faculty
No medical specialty has Black faculty representation in proportion to current U.S. population estimates
Cannabis Use Lower in Cancer Survivors Than General Population
Factors associated with use or nonuse found to be similar between the groups
Minorities, Women Underrepresented in Pancreatic Cancer Trials
84.7 percent of patients in clinical trials were White and 54.8 percent were men; underrepresentation seen in trials of nearly all phases
Doctors More Likely to Test for Conditions Recently Diagnosed in Other Patients
When seeing patients with shortness of breath, testing for pulmonary embolism increases for 10 days after diagnosing a patient with the condition
Model Predicts False-Positives in Breast Cancer MRI Screen
Full prediction model could prevent 45.5 percent of false-positive recalls, 21.3 percent of benign biopsies for those with extremely dense breasts
